SCHEMBL1008065

SCHEMBL1008065

COc1ccc(Cc2nccn2C)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.56
ALDH1A1 P00352 5/20 0.49
POLB P06746 5/20 0.49
LMNA P02545 3/20 0.49
MAPK1 P28482 3/20 0.49
USP2 O75604 2/20 0.49
CYP3A4 P08684 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HIF1A Q16665 2/20 0.49
PDE10A Q9Y233 2/20 0.49
GAA P10253 2/20 0.49
MPI P34949 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
PDE2A O00408 1/20 0.49
ABCC4 O15439 1/20 0.49
PDE5A O76074 1/20 0.49
ABCB11 O95342 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2192386 0.98 CA2 (0.54) CA2ALDH1A1POLBLMNAMAPK1
SCHEMBL16879029 0.87 MAPK1 (0.47) CA2ALDH1A1LMNAMAPK1SMN1; SMN2
SCHEMBL29002529 0.77 TSHR (0.46) ALDH1A1MAPK1SMN1; SMN2GAATSHR
SCHEMBL4856194 0.75 TSHR (0.51) ALDH1A1MAPK1SMN1; SMN2TSHRRAB9A
SCHEMBL2095593 0.74 CA2 (1.00) CA2ALDH1A1POLBLMNAMAPK1
SCHEMBL12409075 0.74 NPC1 (0.50) ALDH1A1POLBMAPK1USP2CYP2C9
SCHEMBL5601356 0.73 CHRNB2 (0.39) ALDH1A1POLBLMNAMAPK1CYP3A4
SCHEMBL3924901 0.72 CA2 (0.66) CA2ALDH1A1POLBLMNAMAPK1
SCHEMBL20871500 0.72 CA2 (0.59) CA2ALDH1A1POLBSMN1; SMN2KDM4E
SCHEMBL20204951 0.72 CYP11B1 (0.45) ALDH1A1POLBMAPTNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268652-B1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-12-19 EP disclosed
EP-2268652-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-01-05 EP disclosed
WO-2009118475-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed